Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Halabi

Showing results (101-110 of 282) with videos related to

Pageof 29
Sort By:
American Journal of Preventive Medicine|May 4, 2002
Effects of a mammography decision-making intervention at 12 and 24 monthsBarbara K Rimer, Susan Halabi, Celette Sugg Skinner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Pain predicts overall survival in men with metastatic castration-refractory prostate cancerSusan Halabi, Nicholas J Vogelzang, Alice B Kornblith, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809Mark D Hurwitz, Susan Halabi, San-San Ou, et al.
American Journal of Epidemiology|February 28, 2008
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal womenPatricia G Moorman, Brian Calingaert, Rachel T Palmieri, et al.
Prostate Cancer and Prostatic Diseases|May 5, 2019
Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)Charles J Ryan, Sandipan Dutta, William K Kelly, et al.
Urology|July 11, 2009
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancerOliver Sartor, David G McLeod, Susan Halabi, et al.
Journal of the National Cancer Institute|February 13, 2009
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trialsBernard F Cole, Richard F Logan, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Activities and accomplishments of the cancer and leukemia group B genitourinary committeeEric J Small, Susan Halabi, Phillip Kantoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapySusan Halabi, Andrew J Armstrong, Oliver Sartor, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2026
Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancerAlicia K Morgans, Christopher J D Wallis, Susan Halabi, et al.
Pageof 29

Showing results (101-110 of 282) with videos related to

Sort By:
Pageof 29
American Journal of Preventive Medicine|May 4, 2002
Effects of a mammography decision-making intervention at 12 and 24 monthsBarbara K Rimer, Susan Halabi, Celette Sugg Skinner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Pain predicts overall survival in men with metastatic castration-refractory prostate cancerSusan Halabi, Nicholas J Vogelzang, Alice B Kornblith, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809Mark D Hurwitz, Susan Halabi, San-San Ou, et al.
American Journal of Epidemiology|February 28, 2008
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal womenPatricia G Moorman, Brian Calingaert, Rachel T Palmieri, et al.
Prostate Cancer and Prostatic Diseases|May 5, 2019
Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)Charles J Ryan, Sandipan Dutta, William K Kelly, et al.
Urology|July 11, 2009
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancerOliver Sartor, David G McLeod, Susan Halabi, et al.
Journal of the National Cancer Institute|February 13, 2009
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trialsBernard F Cole, Richard F Logan, Susan Halabi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Activities and accomplishments of the cancer and leukemia group B genitourinary committeeEric J Small, Susan Halabi, Phillip Kantoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapySusan Halabi, Andrew J Armstrong, Oliver Sartor, et al.
Prostate Cancer and Prostatic Diseases|February 12, 2026
Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancerAlicia K Morgans, Christopher J D Wallis, Susan Halabi, et al.
Pageof 29